Twist Bioscience公司(TWST)今日盘中股价大跌5.08%,引发市场广泛关注。
消息面上,投行摩根士丹利将Twist Bioscience的投资评级维持"减持",但将其目标价从35美元上调至40美元。尽管目标价上调,但"减持"评级意味着分析师对公司前景持谨慎态度,或许是导致该股盘中大幅下跌的主要原因。
Twist Bioscience是一家从事基因合成和基因工程技术服务的生物科技公司。近期公司经营和财报情况等具体因素导致分析师做出上述评级调整,还有待进一步了解和分析。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.